+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ticagrelor versus clopidogrel in high bleeding risk patients with acute coronary syndromes treated with drug-eluting stents



Ticagrelor versus clopidogrel in high bleeding risk patients with acute coronary syndromes treated with drug-eluting stents



International Journal of Cardiology 279: 56




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446732

Download citation: RISBibTeXText

PMID: 30704650

DOI: 10.1016/j.ijcard.2018.09.078


Related references

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT. International Journal of Cardiology 268: 11-17, 2018

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT. Eurointervention 13(10): 1168-1176, 2018

PLATO study of ticagrelor versus clopidogrel in patients with high-risk acute coronary syndromes. Current Cardiology Reports 12(4): 283-285, 2010

The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. Jacc. Cardiovascular Interventions 2(6): 534-541, 2009

Ischemic and bleeding outcomes after coronary artery bypass grafting among patients initially treated with a P2Y 12 receptor antagonist for acute coronary syndromes: Insights on timing of discontinuation of ticagrelor and clopidogrel prior to surgery. European Heart Journal. Acute Cardiovascular Care 2018: 2048872617740832, 2018

Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Chinese Medical Journal 131(17): 2017-2024, 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine 361(11): 1045-1057, 2009

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. Yearbook of Cardiology 2010: 397-399, 2010

Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions. Catheterization and Cardiovascular Interventions 2018, 2018

3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents. Jacc. Cardiovascular Interventions 11(10): 981-991, 2018

Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database of Systematic Reviews 2010(5): Cd004587, 2010

Efficacy and safety of ticagrelor versus clopidogrel with different dosage in high-risk patients with acute coronary syndrome. International Journal of Cardiology 228: 275-279, 2016

Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts. International Journal of Cardiology 248: 20-27, 2017

Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients). Circulation 134(11): 835-837, 2016

Impact of acute coronary syndromes on two-year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents. American Journal of Cardiology 105(2): 174-178, 2010